Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BPTF | Q12830 | 14/20 | 0.52 |
| ▸ | KAT2B | Q92831 | 6/20 | 0.48 |
| ▸ | BRD9 | Q9H8M2 | 5/20 | 0.48 |
| ▸ | BRD4 | O60885 | 4/20 | 0.48 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.47 |
| ▸ | CECR2 | Q9BXF3 | 1/20 | 0.47 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.39 |
| ▸ | KRAS | P01116 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31735828 | 0.85 | BPTF (0.61) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735881 | 0.85 | BPTF (0.53) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735816 | 0.83 | MAOA (0.39) | BPTFKAT2BBRD9BRD4 | |
| SCHEMBL31735780 | 0.82 | BPTF (0.51) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735793 | 0.81 | BPTF (0.51) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735875 | 0.80 | BPTF (0.53) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735577 | 0.80 | BPTF (0.60) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735675 | 0.80 | BPTF (0.54) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735488 | 0.78 | BPTF (0.50) | BPTFKAT2BBRD9BRD4KAT2A | |
| SCHEMBL31735411 | 0.77 | BPTF (0.64) | BPTFKAT2BBRD9BRD4KAT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |